Search research articles
Contact Us
Filters
Showing results (181-190 of 241) with videos related to
Page
of 25
Sort By:
Leukemia & Lymphoma
|
February 26, 2008
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products
Melinda K Gordon, Dorie Sher, Theodore Karrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 13, 2017
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma
Tomer M Mark, Danielle Guarneri, Peter Forsberg, et al.
Scientific Reports
|
July 25, 2019
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
Yogindra Vedvyas, Jaclyn E McCloskey, Yanping Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2016
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning
Stephanie B Tsai, Hongtao Liu, Tsiporah Shore, et al.
Bone Marrow Transplantation
|
June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
Alexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Blood
|
October 7, 2011
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions
Hongtao Liu, Elizabeth S Rich, Lucy Godley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia
Jingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Leukemia & Lymphoma
|
February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
Koen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2016
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy
Katarzyna Rojek, Eric Nickels, Barbara Neistadt, et al.
Leukemia & Lymphoma
|
September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)
Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 241) with videos related to
Sort By:
Page
of 25
Leukemia & Lymphoma
|
February 26, 2008
Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products
Melinda K Gordon, Dorie Sher, Theodore Karrison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 13, 2017
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma
Tomer M Mark, Danielle Guarneri, Peter Forsberg, et al.
Scientific Reports
|
July 25, 2019
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
Yogindra Vedvyas, Jaclyn E McCloskey, Yanping Yang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 26, 2016
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning
Stephanie B Tsai, Hongtao Liu, Tsiporah Shore, et al.
Bone Marrow Transplantation
|
June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
Alexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Blood
|
October 7, 2011
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions
Hongtao Liu, Elizabeth S Rich, Lucy Godley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 13, 2017
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia
Jingmei Hsu, Andrew Artz, Sebastian A Mayer, et al.
Leukemia & Lymphoma
|
February 12, 2019
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk
Koen Van Besien, Lizamarie Bachier-Rodriguez, Michael Satlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 8, 2016
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy
Katarzyna Rojek, Eric Nickels, Barbara Neistadt, et al.
Leukemia & Lymphoma
|
September 15, 2011
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML)
Sarah M Larson, Nicholas P Campbell, Dezheng Huo, et al.
Page
of 25